knowledge -WSS

knowledge

author：hotspot 2025-09-28 23:11:02 - browse：569

Alzheimer’s disease has killed at least three women in Astrida Schaeffer’s family over two generations, leaving her feeling helpless and bereft.

The first was her Polish-born maternal grandmother, who began showing symptoms when Schaeffer started college in 1981 and died seven years later. Then came her mother, a onetime Fulbright Scholar and high school language teacher who had been fluent in five languages but lost the ability to speak. She died in 2019. Last year, the disease killed Schaeffer’s mother’s sister, a former lab technician for Johnson & Johnson.

Schaeffer, a 59-year-old costume historian in North Berwick, Maine, has no symptoms of Alzheimer’s. But in 2021 her family history led her to apply to join a clinical trial testing a drug on people at risk for developing them. To participate, volunteers couldn’t have cognitive impairment. But they needed to test positive for a biomarker that put them at higher risk for mental decline ― deposits of a sticky toxic protein in the brain called beta-amyloid that is a hallmark of the disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： It's time to retire 'poor historian' from clinicians' vocabularies

leisure time

WSS

Dems pitch expanding Medicare power to negotiate drug prices

It's time to retire 'poor historian' from clinicians' vocabularies

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Why patients can’t get everything they want on drug pricing

Helping hospitals and community health centers plan for resilience

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

hotspot

knowledge

focus

Affirmative action in medical school literally saved lives

New lawsuit accuses health insurer Cigna of denying claims in bulk

Tori Bowie and the unacceptable rates of Black maternal death

CDC Director Mandy Cohen on transparency, trust, and health

Trump demands the U.S. pay no more for drugs than other countries … again

HIV vaccine remains elusive. Immunologists keep trying new ideas

Virginia high school admissions case could be legal follow

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Bright Health sells Medicare Advantage business to Molina

Rise in cancer among younger people worries and puzzles doctors

explore

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Rise in cancer among younger people worries and puzzles doctors

Wearables generate powerful data but its not useful to doctors, yet

Truvian presents data for its desktop blood

CDC Director Mandy Cohen on transparency, trust, and health

Addiction experts warn against a second 'war on drugs'

explore

focus

leisure time

explore